Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most TF cases (67%, 4/6) occurred in children aged 5–15 years, aligning with studies from Ethiopia [25] but differing from a study in Myanmar, where TF cases were more common in adults [40].”
In the citing paper
“This finding is in line with studies from Myanmar [40] and demonstrates faster fever clearance compared to studies in Southwest Ethiopia, where CQ alone showed delayed fever clearance [23].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malaria in the Greater Mekong Subregion: heterogeneity and complexity.
Cui, L., Yan, G., Sattabongkot, J., Cao, Y., Chen, B., Chen, X., Fan, Q., Fang, Q., Jongwutiwes, S., Parker, D., et al. (2012) · Acta Tropica · doi:10.1016/j.actatropica.2011.02.016 · Cited by 277 · cited 1×
“In the GMS, most malaria transmission occurs along international borders [16, 17].”
BackgroundSelf-citation
Research works printed but not linked: 29
- Baird, 2017, Asia-Pacific malaria is singular, pervasive, diverse and invisible, Int J Parasitol, 47, 371, 10.1016/j.ijpara.2016.06.006 · DOI
- Howes, 2016, Global epidemiology of plasmodium vivax, Am J Trop Med Hyg, 95, 15, 10.4269/ajtmh.16-0141 · DOI · Paper page
- Baird, 2009, Resistance to therapies for infection by Plasmodium vivax, Clin Microbiol Rev, 22, 508, 10.1128/CMR.00008-09 · DOI · Paper page
- Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect Dis, 14, 982, 10.1016/S1473-3099(14)70855-2 · DOI · Paper page
- Takala-Harrison, 2015, Antimalarial drug resistance in Africa: key lessons for the future, Ann N Y Acad Sci, 1342, 62, 10.1111/nyas.12766 · DOI
- Schuurkamp, 1992, Chloroquine-resistant plasmodium vivax in Papua New Guinea, Trans R Soc Trop Med Hyg, 86, 121, 10.1016/0035-9203(92)90531-G · DOI · Paper page
- Guthmann, 2008, Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar, Trop Med Int Health, 13, 91, 10.1111/j.1365-3156.2007.01978.x · DOI
- Yohannes, 2011, Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in Ethiopia, Am J Trop Med Hyg, 84, 137, 10.4269/ajtmh.2011.09-0723 · doi:10.4269/ajtmh.2011.09-0723
- Thanh, 2015, Confirmed plasmodium vivax resistance to chloroquine in central Vietnam, Antimicrob Agents Chemother, 59, 7411, 10.1128/AAC.00791-15 · DOI
- Saravu, 2016, Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of plasmodium vivax malaria from primary care centres in Southwestern India, PLoS One, 11, e0157666, 10.1371/journal.pone.0157666 · DOI · Paper page
- Wangchuk, 2016, Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan, Malar J, 15, 277, 10.1186/s12936-016-1320-8 · DOI
- Chu, 2018, Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in plasmodium vivax malaria, Clin Infect Dis, 67, 1543, 10.1093/cid/ciy319 · DOI · Paper page
- Delacollette, 2009, Malaria trends and challenges in the greater Mekong subregion, Southeast Asian J Trop Med Public Health, 40, 674
- Liu, 2014, Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008-2013, Malar J, 13, 364, 10.1186/1475-2875-13-364 · DOI
- Myat Phone, 1993, Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma), Trans R Soc Trop Med Hyg, 87, 687, 10.1016/0035-9203(93)90294-Z · DOI
- Marlar, 1995, Development of resistance to chloroquine by Plasmodium vivax in Myanmar, Trans R Soc Trop Med Hyg, 89, 307, 10.1016/0035-9203(95)90556-1 · DOI
- Yuan, 2015, Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar, Antimicrob Agents Chemother, 59, 1230, 10.1128/AAC.04270-14 · DOI · Paper page
- Htun, 2017, Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow, Malar J, 16, 281, 10.1186/s12936-017-1912-y · DOI
- Zhou, 2016, Impact of interventions on malaria in internally displaced persons along the China-Myanmar border: 2011-2014, Malar J, 15, 471, 10.1186/s12936-016-1512-2 · DOI
- Li, 2016, Plasmodium malariae and Plasmodium ovale infections in the China-Myanmar border area, Malar J, 15, 557, 10.1186/s12936-016-1605-y · DOI
- Liu, 2016, A more appropriate white blood cell count for estimating malaria parasite density in Plasmodium vivax patients in northeastern Myanmar, Acta Trop, 156, 152, 10.1016/j.actatropica.2016.01.018 · DOI
- Singh, 1999, A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies, Am J Trop Med Hyg, 60, 687, 10.4269/ajtmh.1999.60.687 · DOI · Paper page
- Leclerc, 2005, Genetic diversity of merozoite surface protein-1 gene of Plasmodium vivax isolates in mining villages of Venezuela (Bolivar State), Acta Trop, 95, 26, 10.1016/j.actatropica.2005.03.007 · DOI
- Baird, 1997, Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels, Am J Trop Med Hyg, 56, 621, 10.4269/ajtmh.1997.56.621 · DOI · Paper page
- Lin, 2015, Using amplicon deep sequencing to detect genetic signatures of plasmodium vivax relapse, J Infect Dis, 212, 999, 10.1093/infdis/jiv142 · DOI
- Zhong, 2018, Multiplicity and molecular epidemiology of Plasmodium vivax and Plasmodium falciparum infections in East Africa, Malar J, 17, 185, 10.1186/s12936-018-2337-y · DOI
- Pukrittayakamee, 2000, Therapeutic responses to different antimalarial drugs in vivax malaria, Antimicrob Agents Chemother, 44, 1680, 10.1128/AAC.44.6.1680-1685.2000 · DOI · Paper page
- Maneeboonyang, 2011, Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border, Southeast Asian J Trop Med Public Health, 42, 9
- Hanscheid, 2018, How "resistant" is artemisinin resistant malaria? - the risks of ambiguity using the term "resistant" malaria, Trav Med Infect Dis, 24, 23, 10.1016/j.tmaid.2018.04.008 · DOI
Cited by
Getu, E., Biruksew, A., Eshetu, T., Abamecha, A., Assefa, D. G., Mohammed, H., Wuletaw, Y., Tasew, G., Tollera, G., Hailu, M., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05446-y · Cited by 4
Metadata
- Authors
- Xu, S., Zeng, W., Ngassa Mbenda, H. G., Liu, H., Chen, X., Xiang, Z., Li, C., Zhang, Y., Baird, J. K., Yang, Z., & Cui, L.
- Venue
- Travel Medicine and Infectious Disease
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 36
- Pages
- 101499
- ISSN
- 1477-8939
- Cited by
- 25
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- National Natural Science Foundation of China
- National Institutes of Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.